Medtronic plc (MDT)

NYSE: MDT · IEX Real-Time Price · USD
83.55
-0.30 (-0.35%)
Feb 28, 2024, 2:27 PM EST - Market open
-0.35%
Market Cap 111.25B
Revenue (ttm) 32.32B
Net Income (ttm) 4.20B
Shares Out 1.33B
EPS (ttm) 3.14
PE Ratio 26.56
Forward PE 16.02
Dividend $2.76 (3.30%)
Ex-Dividend Date Dec 19, 2023
Volume 1,991,998
Open 83.63
Previous Close 83.84
Day's Range 83.33 - 83.83
52-Week Range 68.84 - 92.02
Beta 0.79
Analysts Buy
Price Target 96.00 (+14.91%)
Earnings Date Feb 20, 2024

About MDT

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accesso... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1949
Employees 95,000
Stock Exchange NYSE
Ticker Symbol MDT
Full Company Profile

Financial Performance

In 2023, Medtronic's revenue was $31.23 billion, a decrease of -1.45% compared to the previous year's $31.69 billion. Earnings were $3.76 billion, a decrease of -25.42%.

Financial Statements

Analyst Forecast

According to 13 analysts, the average rating for MDT stock is "Buy." The 12-month stock price forecast is $96.0, which is an increase of 14.91% from the latest price.

Price Target
$96.0
(14.91% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Medtronic Nixes Spinoff Plans For Monitoring And Respiratory Units

Medtronic's choice to retain its PMRI Business is mainly driven by the improved performance of its Patient Monitoring segment in recent times, is a result of a comprehensive evaluation of its portfoli...

6 days ago - Forbes

Medtronic Beats Estimates and Boosts Outlook on Heart, Diabetes Device Sales

Shares of Medtronic PLC (MDT) gained Tuesday after the medical technology firm posted better-than-expected results and raised its guidance on increased demand for its heart and diabetes devices.

8 days ago - Investopedia

Medtronic CEO on earnings: Back to growth in China after challenging few years

Geoff Martha, Medtronic CEO, joins 'Money Movers' to discuss the company's quarterly earnings results, Medtronic's business in China, and how Martha is thinking about the company's portfolio.

8 days ago - CNBC Television

Medtronic Stock Jumps. Medical Device Maker Tops Earnings and Raises Forecast.

Medtronic reported adjusted per-share earnings of $1.30, beating Wall Street's call for $1.26, according to FactSet.

8 days ago - Barrons

Medtronic beats profit estimates on strong demand for heart devices

Medtronic beat Wall Street estimates for third-quarter profit on Tuesday, aided by strong demand for its heart and diabetes devices.

8 days ago - Reuters

Medtronic reports third quarter fiscal 2024 financial results

Delivers on commitments with strong growth in Core Spine, Cardiac Surgery, Structural Heart, Cardiac Pacing, and across many international markets; Diabetes increases double digits as U.S. business re...

8 days ago - PRNewsWire

Medtronic to announce financial results for its third quarter of fiscal year 2024

DUBLIN , Feb. 6, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its third quarter of fiscal year 202...

22 days ago - PRNewsWire

Up Just 6% In 2023 Is Medtronic Stock A Better Pick Over Abbott?

Given its better prospects, we believe Medtronic stock (NYSE: MDT) is a better pick than its peer, Abbott stock (NYSE: ABT). Abbott trades at a higher valuation multiple of 4.9x revenues vs.

Other symbols: ABT
4 weeks ago - Forbes

Medtronic receives FDA approval for deep brain stimulation system

Medtronic PLC NYSE: MDT, a member of the medical sector and the healthcare industry, received U.S. FDA approval for its implantable medical device called the Percept PC Deep Brain Stimulation (DBS) sy...

6 weeks ago - MarketBeat

10 Healthcare Stocks That Are Heating Up

The sector has seen one of the best starts to the year in decades, Goldman says.

6 weeks ago - Barrons

Medtronic CEO: The amount of data you have is going to be your currency for innovation

Medtronic CEO Geoffrey Martha, with CNBC's Jim Cramer, joins 'The Exchange' to discuss the impact of weight-loss drugs, AI-driven care, and more.

7 weeks ago - CNBC Television

FDA approves Medtronic Percept™ RC neurostimulator with exclusive BrainSense™ technology

Rechargeable neurostimulator joins the Medtronic Percept ™ family – the first and only deep brain stimulation system with sensing, directionality, and advanced programming. DUBLIN , Jan. 8, 2024 /PRNe...

7 weeks ago - PRNewsWire

Medtronic Diabetes announces world's first approval for MiniMed™ 780G System with Simplera Sync™ disposable, all-in-one sensor

With CE Mark approval, the benefits of the MiniMed™ 780G system are now available with a new sensor that takes less than 10 seconds to insert1 DUBLIN , Jan. 8, 2024 /PRNewswire/ -- Medtronic plc  (NYS...

7 weeks ago - PRNewsWire

Medtronic receives CE Mark for its next generation Micra leadless pacing systems

New pacemakers offer 40% more battery life,1 extend Medtronic legacy of pacing leadership DUBLIN , Jan. 5, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, tod...

7 weeks ago - PRNewsWire

Ozempic and other weight-loss drugs' popularity set these stocks up for big gains

Investors have such high hopes for popular weight-loss medications like Wegovy and Ozempic, the wonder drugs have sent shock waves through the stock market.

7 weeks ago - Market Watch

Final Trade: ETH, BABA, MDT, ET

The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.

Other symbols: BABAETETHE
2 months ago - CNBC Television

Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference

DUBLIN , Dec. 18, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 42nd annual J.P. Morgan healthcare conference on M...

2 months ago - PRNewsWire

Medtronic gets FDA approval for new heart-condition treatment

Medtronic said the U.S. Food and Drug Administration has approved its PulseSelect Pulsed Field Ablation System for the treatment of two heart conditions.

2 months ago - Market Watch

US FDA approves Medtronic's system for heart condition

Medtronic said on Wednesday that the U.S. Food and Drug Administration (FDA) had approved its system for a type of condition that can cause stroke or heart failure.

2 months ago - Reuters

Medtronic creates history with FDA approval of its novel PulseSelect™ Pulsed Field Ablation System to treat atrial fibrillation

Safe, efficient, and effective treatment for both paroxysmal and persistent atrial fibrillation DUBLIN , Dec. 13, 2023 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technolo...

2 months ago - PRNewsWire

3 of the Best Stocks for Value Investors to Buy Now

#Morningstar  #ComcastStock #StockInvesting These cheap stocks from companies with wide economic moats look attractive for 2024. 00:00 Introduction 00:46 Medtronic MDT 01:21 Comcast CMCSA 02:00 RTX RT...

Other symbols: CMCSARTX
2 months ago - Morningstar

Cosmo Pharmaceuticals and Medtronic Forge Ahead in AI-Driven Care

Agreement Expands Partnership Between Cosmo Pharmaceuticals and Medtronic, Set to Transform Endoscopy with Cutting-Edge AI Technology Ad hoc announcement pursuant to Art. 53 LR Dublin, Ireland--(Newsf...

2 months ago - Newsfile Corp

Medtronic and Cosmo Pharmaceuticals forge ahead in AI-driven care

Agreement expands partnership between Medtronic and Cosmo Pharmaceuticals, set to transform endoscopy with cutting-edge AI technology DUBLIN , Dec. 11, 2023 /PRNewswire/ -- Medtronic plc (NYSE: MDT), ...

2 months ago - PRNewsWire

Medtronic announces cash dividend for third quarter of fiscal year 2024

DUBLIN , Dec. 7, 2023 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE:MDT) on Thursday, December 7, 2023, approved the company's cash dividend for the third quarter of fiscal year 2024 o...

2 months ago - PRNewsWire

Best Long-Term Investment Stocks to Buy

Some of the best long-term investment stocks include companies that are in good financial standing, have a low valuation and pay consistent dividends.

Other symbols: AAPLCVXKOMCDMMMMSFTPG
3 months ago - Kiplinger